Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Miao Han, Min Chen, Yunqiu Du, Yuhua Sun, Yue Zhang, Zhiwei Wang, Fang Zhang, Ting Yin, Leilei Wang, Xinxin Tang
Format: Artículo Open Access
Veröffentlicht: Wiley 2026
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867011761161371648
author Miao Han
Min Chen
Yunqiu Du
Yuhua Sun
Yue Zhang
Zhiwei Wang
Fang Zhang
Ting Yin
Leilei Wang
Xinxin Tang
author_facet Miao Han
Min Chen
Yunqiu Du
Yuhua Sun
Yue Zhang
Zhiwei Wang
Fang Zhang
Ting Yin
Leilei Wang
Xinxin Tang
Miao Han
Min Chen
Yunqiu Du
Yuhua Sun
Yue Zhang
Zhiwei Wang
Fang Zhang
Ting Yin
Leilei Wang
Xinxin Tang
collection Wiley Open Access
contents Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis Miao Han Min Chen Yunqiu Du Yuhua Sun Yue Zhang Zhiwei Wang Fang Zhang Ting Yin Leilei Wang Xinxin Tang Prenatal Diagnosis ABSTRACT Objective This study aimed to evaluated the clinical utility of an integrated prenatal screening strategy combining non‐invasive prenatal testing (NIPT) and maternal serum unconjugated estriol (uE3) quantification for detecting X‐linked ichthyosis (XLI) in male fetuses. Methods Within a retrospective cohort of 95,485 screened pregnancies, 147 cases exhibiting low second‐trimester uE3 levels (Multiple of the Median, MoM ≤ 0.3) were identified. Participants were stratified based on uE3 MoM values into Group 1 (uE3 ≤ 0.1) and Group 2 (0.1 < uE3 ≤ 0.3). NIPT was performed in 41 cases to detect maternal Xp22.31 microdeletions encompassing the STS gene. Fetal genotypes were verified via chromosomal microarray analysis (CMA) of amniotic fluid in cases opting for invasive prenatal diagnosis. For those without prenatal diagnosis, verification was conducted by STS ‐specific PCR using newborn heel blood samples. Results The incidence of confirmed XLI was significantly higher in Group 1 (49.3%, 35/71) than in Group 2 (1.3%, 1/76). Among the 41 cases that underwent NIPT, maternal Xp22.31 deletions were detected in 28 cases. When this deletion combined with an extremely low maternal serum uE3 level (MoM ≤ 0.3), the positive predictive value for XLI reached 100%, which was markedly higher than that of NIPT alone (theoretical ∼50% PPV) or uE3 screening alone (49.3% PPV). Conclusion Integrating NIPT‐based maternal CNV detection with maternal serum uE3 quantification significantly improves the accuracy of prenatal XLI screening. This combined approach is most clinically actionable in a specific scenario: a male fetus presenting with normal ultrasound findings, extremely low maternal uE3, and a positive family history of isolated XLI without comorbidities. 10.1002/pd.70139 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/pd.70139
format Artículo Open Access
id wiley_oa_10_1002_pd_70139
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis
Miao Han
Min Chen
Yunqiu Du
Yuhua Sun
Yue Zhang
Zhiwei Wang
Fang Zhang
Ting Yin
Leilei Wang
Xinxin Tang
Prenatal Diagnosis
Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis Miao Han Min Chen Yunqiu Du Yuhua Sun Yue Zhang Zhiwei Wang Fang Zhang Ting Yin Leilei Wang Xinxin Tang Prenatal Diagnosis ABSTRACT Objective This study aimed to evaluated the clinical utility of an integrated prenatal screening strategy combining non‐invasive prenatal testing (NIPT) and maternal serum unconjugated estriol (uE3) quantification for detecting X‐linked ichthyosis (XLI) in male fetuses. Methods Within a retrospective cohort of 95,485 screened pregnancies, 147 cases exhibiting low second‐trimester uE3 levels (Multiple of the Median, MoM ≤ 0.3) were identified. Participants were stratified based on uE3 MoM values into Group 1 (uE3 ≤ 0.1) and Group 2 (0.1 < uE3 ≤ 0.3). NIPT was performed in 41 cases to detect maternal Xp22.31 microdeletions encompassing the STS gene. Fetal genotypes were verified via chromosomal microarray analysis (CMA) of amniotic fluid in cases opting for invasive prenatal diagnosis. For those without prenatal diagnosis, verification was conducted by STS ‐specific PCR using newborn heel blood samples. Results The incidence of confirmed XLI was significantly higher in Group 1 (49.3%, 35/71) than in Group 2 (1.3%, 1/76). Among the 41 cases that underwent NIPT, maternal Xp22.31 deletions were detected in 28 cases. When this deletion combined with an extremely low maternal serum uE3 level (MoM ≤ 0.3), the positive predictive value for XLI reached 100%, which was markedly higher than that of NIPT alone (theoretical ∼50% PPV) or uE3 screening alone (49.3% PPV). Conclusion Integrating NIPT‐based maternal CNV detection with maternal serum uE3 quantification significantly improves the accuracy of prenatal XLI screening. This combined approach is most clinically actionable in a specific scenario: a male fetus presenting with normal ultrasound findings, extremely low maternal uE3, and a positive family history of isolated XLI without comorbidities. 10.1002/pd.70139 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis
topic Prenatal Diagnosis
url https://obgyn.onlinelibrary.wiley.com/doi/10.1002/pd.70139